Selpercatinib
About
Therapy type: Targeted therapy
Therapy strategy: RET inhibition
Mappings
NCI Thesaurus: Selpercatinib (ncit:C134987)
RxNorm: selpercatinib (rxcui:2370147, omop:1145791)
SNOMED: Selpercatinib (sctid:876841001, omop:618816)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | v::RET | Non-Small Cell Lung Cancer | Selpercatinib | |
| FDA (1) | RET oncogenic variants | Medullary Thyroid Cancer | Selpercatinib | |
| FDA (1) | v::RET | Anaplastic Thyroid Cancer | Selpercatinib | |
| EMA (1) FDA (1) | v::RET | Any solid tumor | Selpercatinib | |
| EMA (1) | v::RET | Papillary Thyroid Cancer | Selpercatinib | |
| EMA (1) | RET p.M918T | Medullary Thyroid Cancer | Selpercatinib |